ArticlePharmaceutics2021

Acceptability of a Sublingual Drug Formulation for Respiratory Tract Infections in Children Aged 3 to 5 Years.

Andrzej Emeryk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.